Semaglutide, the active ingredient in Ozempic, and other drugs in the same class have revolutionized the treatment of obesity and type 2 diabetes. Now, a clinical trial suggests the medicines can ...

Fact checked by Jillian Dara The Food and Drug Administration (FDA) on Tuesday approved Ozempic (semaglutide) to reduce the risk of complications and death in adults with both type 2 diabetes and ...

Ozempic, for diabetes, and Wegovy, for weight loss, use the active ingredient semaglutide. All four drugs are part of a GLP-1 class of treatments that has shown unprecedented results for helping ...

Here’s how it works. GLP-1 agonists, the class of drug that includes Ozempic, may be useful for managing type 1 diabetes. (Image credit: Tatsiana Volkava via Getty Images) ...